Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium

被引：10

作者：

Piccini, Jonathan P. ^{[1
,2
]}

Clark, Richard L. ^{[3
]}

Kowey, Peter R. ^{[4
,5
]}

Mittal, Suneet ^{[6
]}

Dunnmon, Preston ^{[7
]}

Stockbridge, Norman ^{[7
]}

Reiffel, James A. ^{[8
]}

Turakhia, Mintu P. ^{[9
,10
]}

Ziegler, Paul D. ^{[3
]}

Kleiman, Robert B. ^{[11
]}

Ismat, Fraz ^{[12
]}

Sager, Philip ^{[13
]}

机构：

[1] Duke Univ, Med Ctr, Durham, NC 27708 USA

[2] Duke Clin Res Inst, Durham, NC 27705 USA

[3] Mechron Diagnost & Monitoring Res, Mounds View, MN USA

[4] Lankenau Heart Inst, Philadelphia, PA USA

[5] Jefferson Med Coll, Philadelphia, PA USA

[6] Valley Hlth Syst, Ridgewood, NJ USA

[7] US FDA, Div Cardiovasc & Renal Prod, Rockville, MD 20857 USA

[8] Columbia Univ, Div Cardiol, Med Ctr, New York, NY USA

[9] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA

[10] Stanford Univ, Palo Alto, CA 94304 USA

[11] eRes Technol Inc ERT, Philadelphia, PA USA

[12] Bristol Myers Squibb, Princeton, NJ USA

[13] Stanford Univ, Stanford, CA 94305 USA

来源：

AMERICAN HEART JOURNAL | 2017年 / 187卷

关键词：

ATRIAL-FIBRILLATION; PROARRHYTHMIC RISK; HEPATITIS-C; SOFOSBUVIR; ARRHYTHMIAS; AMIODARONE; DEVICES; FOCUS;

D O I：

10.1016/j.ahj.2017.01.012

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This white paper, prepared by members of the Cardiac Safety Research Consortium (CSRC), discusses important issues regarding scientific and clinical aspects of long-term electrocardiographic safety monitoring during clinical drug development. To promote multistakeholder discussion of this topic, a Cardiac Safety Research Consortium sponsored Think Tank was held on 2 December 2015 at the American College of Cardiology's Heart House in Washington, DC. The goal of the Think Tank was to explore how and under what circumstances new and evolving ambulatory monitoring technologies could be used to improve and streamline drug development. This paper provides a detailed summary of discussions at the Think Tank: it does not represent regulatory guidance.

引用

页码：156 / 169

页数：14

共 50 条

[21] Electrocardiographic patterns and long-term clinical outcome in cardiac resynchronization therapy
Kronborg, Mads B.
Nielsen, Jens C.
Mortensen, Peter T.
EUROPACE, 2010, 12 (02): : 216 - 222
[22] PRELIMINARY-REPORT - LONG-TERM SAFETY OF ZOMEPIRAC
HONIG, S
JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 20 (5-6): : 392 - 396
[23] Cardiac Safety and Clinical Efficacy of High Dose Domperidone for Long-Term Treatment of Gastroparesis
Woods, Kevin
Sarosiek, Irene
Espino, Karina
Ramirez, Marisol
Siddiqui, Tariq
McCallum, Richard
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S685 - S685
[24] Long-term Research Project started SAFETY OF NANOMATERIALS
不详
ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE, 2012, 62 (03): : 147 - 147
[25] Long-term effectiveness and safety of liraglutide in clinical practice
Ponzani, P.
MINERVA ENDOCRINOLOGICA, 2013, 38 (01) : 103 - 112
[26] Long-term Effectiveness and Safety of Liraglutide in Clinical Practice
Ponzani, Paola
Rossi, Maria Chiara
Nicolucci, Antonio
DIABETES, 2014, 63 : A259 - A259
[27] Assessing Long-Term Drug Safety: Lessons (Re) Learned from Raptiva
Seminara, Nicole M.
Gelfand, Joel M.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2010, 29 (01) : 16 - 19
[28] Troponin measurements during drug development-considerations for monitoring and management of potential cardiotoxicity: An educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration
Newby, L. Kristin
Rodriguez, Ignacio
Finkle, John
Becker, Richard C.
Hicks, Karen A.
Hausner, Elizabeth
Chesler, Ruth
Harper, Courtney
Targum, Shari
Berridge, Brian R.
Lewis, Eric
Walker, Dana B.
Dollery, Colin
Turner, J. Rick
Krucoff, Mitchell W.
AMERICAN HEART JOURNAL, 2011, 162 (01) : 64 - 73
[29] Safety study of long-term video-electroencephalogram monitoring
Ley, M.
Vivanco, R.
Massot, A.
Jimenez, J.
Roquer, J.
Rocamora, R.
NEUROLOGIA, 2014, 29 (01): : 21 - 26
[30] Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium
Heller, Simon
Darpoe, Boerje
Mitchell, Malcolm I.
Linnebjerg, Helle
Leishman, Derek J.
Mehrotra, Nitin
Zhu, Hao
Koerner, John
Fiszman, Monica L.
Balakrishnan, Suchitra
Xiao, Shen
Todaro, Thomas G.
Hensley, Ingrid
Guth, Brian D.
Michelson, Eric L.
Sager, Philip
AMERICAN HEART JOURNAL, 2015, 170 (01) : 23 - 35

← 1 2 3 4 5 →